These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10674623)

  • 1. Neurofibrillary tangles in progressive supranuclear palsy brains exhibit immunoreactivity to frameshift mutant ubiquitin-B protein.
    Fergusson J; Landon M; Lowe J; Ward L; van Leeuwen FW; Mayer RJ
    Neurosci Lett; 2000 Jan; 279(2):69-72. PubMed ID: 10674623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional quantitative analysis of tau-positive neurons in progressive supranuclear palsy: comparison with Alzheimer's disease.
    Li F; Iseki E; Odawara T; Kosaka K; Yagishita S; Amano N
    J Neurol Sci; 1998 Jul; 159(1):73-81. PubMed ID: 9700707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofibrillary tangles in progressive supranuclear palsy contain the same tau epitopes identified in Alzheimer's disease PHFtau.
    Schmidt ML; Huang R; Martin JA; Henley J; Mawal-Dewan M; Hurtig HI; Lee VM; Trojanowski JQ
    J Neuropathol Exp Neurol; 1996 May; 55(5):534-9. PubMed ID: 8627344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-labeling immunohistochemical study of tau exon 10 in Alzheimer's disease, progressive supranuclear palsy and Pick's disease.
    Ishizawa K; Ksiezak-Reding H; Davies P; Delacourte A; Tiseo P; Yen SH; Dickson DW
    Acta Neuropathol; 2000 Sep; 100(3):235-44. PubMed ID: 10965792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and pathological study of two patients with progressive supranuclear palsy and Alzheimer's changes. Antigenic determinants that distinguish cortical and subcortical neurofibrillary tangles.
    Cruz-Sanchez FF; Rossi ML; Cardozo A; Deacon P; Tolosa E
    Neurosci Lett; 1992 Feb; 136(1):43-6. PubMed ID: 1321966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Processing of Tau Protein in Progressive Supranuclear Palsy: Neuronal and Glial Degeneration.
    Martínez-Maldonado A; Ontiveros-Torres MÁ; Harrington CR; Montiel-Sosa JF; Prandiz RG; Bocanegra-López P; Sorsby-Vargas AM; Bravo-Muñoz M; Florán-Garduño B; Villanueva-Fierro I; Perry G; Garcés-Ramírez L; de la Cruz F; Martínez-Robles S; Pacheco-Herrero M; Luna-Muñoz J
    J Alzheimers Dis; 2021; 79(4):1517-1531. PubMed ID: 33459640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transglutaminase-induced cross-linking of tau proteins in progressive supranuclear palsy.
    Zemaitaitis MO; Lee JM; Troncoso JC; Muma NA
    J Neuropathol Exp Neurol; 2000 Nov; 59(11):983-9. PubMed ID: 11089576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebellar cortical tau pathology in progressive supranuclear palsy and corticobasal degeneration.
    Piao YS; Hayashi S; Wakabayashi K; Kakita A; Aida I; Yamada M; Takahashi H
    Acta Neuropathol; 2002 May; 103(5):469-74. PubMed ID: 11935262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurofibrillary pathology in progressive supranuclear palsy (PSP).
    Cervós-Navarro J; Schumacher K
    J Neural Transm Suppl; 1994; 42():153-64. PubMed ID: 7964685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurofibrillary tangles in the neurons of spinal dorsal root ganglia of patients with progressive supranuclear palsy.
    Nishimura M; Namba Y; Ikeda K; Akiguchi I; Oda M
    Acta Neuropathol; 1993; 85(5):453-7. PubMed ID: 8388145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smad ubiquitination regulatory factor-2 in progressive supranuclear palsy.
    Nakamura M; Ito H; Nakamura Y; Wate R; Kaneko S; Nakano S; Matsumoto S; Kusaka H
    Neuropathol Appl Neurobiol; 2011 Apr; 37(3):307-14. PubMed ID: 20819168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive supranuclear palsy: extensive neuropil threads in addition to neurofibrillary tangles. Very similar antigenicity of subcortical neuronal pathology in progressive supranuclear palsy and Alzheimer's disease.
    Probst A; Langui D; Lautenschlager C; Ulrich J; Brion JP; Anderton BH
    Acta Neuropathol; 1988; 77(1):61-8. PubMed ID: 3149122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatial topography of the neurofibrillary tangles in cortical and subcortical regions in progressive supranuclear palsy.
    Armstrong RA; Lantos PL; Cairns NJ
    Parkinsonism Relat Disord; 2007 Feb; 13(1):50-4. PubMed ID: 17046313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase of cdk5 is related to neurofibrillary pathology in progressive supranuclear palsy.
    Borghi R; Giliberto L; Assini A; Delacourte A; Perry G; Smith MA; Strocchi P; Zaccheo D; Tabaton M
    Neurology; 2002 Feb; 58(4):589-92. PubMed ID: 11865137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure in heat-shock protein expression in response to UBB+1 protein in progressive supranuclear palsy in humans.
    Hope AD; Lashley T; Lees AJ; de Silva R
    Neurosci Lett; 2004 Apr; 359(1-2):94-8. PubMed ID: 15050720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E epsilon 4 allele frequency is not increased in progressive supranuclear palsy.
    Tabaton M; Rolleri M; Masturzo P; Cammarata S; Angelini G; Hansen LA; Saitoh T; Petersen RB; Perry G; Richey P
    Neurology; 1995 Sep; 45(9):1764-5. PubMed ID: 7675243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of four-repeat tau mRNA isoforms in progressive supranuclear palsy but not in Alzheimer's disease.
    Chambers CB; Lee JM; Troncoso JC; Reich S; Muma NA
    Ann Neurol; 1999 Sep; 46(3):325-32. PubMed ID: 10482263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tau accumulation in astrocytes in progressive supranuclear palsy is a degenerative rather than a reactive process.
    Togo T; Dickson DW
    Acta Neuropathol; 2002 Oct; 104(4):398-402. PubMed ID: 12200627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical study of a case with progressive supranuclear palsy without ophthalmoplegia.
    Kida E; Barcikowska M; Niemczewska M
    Acta Neuropathol; 1992; 83(3):328-32. PubMed ID: 1557959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.